EP0847528A1 - Magnetische nanopartikel gehoppelt an annexine und ihre verwendung - Google Patents

Magnetische nanopartikel gehoppelt an annexine und ihre verwendung

Info

Publication number
EP0847528A1
EP0847528A1 EP96922967A EP96922967A EP0847528A1 EP 0847528 A1 EP0847528 A1 EP 0847528A1 EP 96922967 A EP96922967 A EP 96922967A EP 96922967 A EP96922967 A EP 96922967A EP 0847528 A1 EP0847528 A1 EP 0847528A1
Authority
EP
European Patent Office
Prior art keywords
cells
effector
ffsh
annexin
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96922967A
Other languages
English (en)
French (fr)
Inventor
Avraham Halbreich
Domagoj Sabolovic
Claude Sestier
Danielle Geldwerth
Jean-Noel Pons
Jacky Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie Paris 6
Original Assignee
Universite Pierre et Marie Curie Paris 6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Pierre et Marie Curie Paris 6 filed Critical Universite Pierre et Marie Curie Paris 6
Publication of EP0847528A1 publication Critical patent/EP0847528A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00—Magnetic separation
    • B03C1/005—Pretreatment specially adapted for magnetic separation
    • B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/44—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/832—Nanostructure having specified property, e.g. lattice-constant, thermal expansion coefficient
    • Y10S977/838—Magnetic property of nanomaterial
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/93—MRI contrast agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated

Definitions

  • Anx FF particles of the invention can be used in the manufacture of a medicament intended to treat the immune deficiencies induced by viruses or parasites.
  • Figure 4 Retention rate of erythrocytes by Anx FF as a function of the number of cells used in the test.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Power Engineering (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP96922967A 1995-06-29 1996-06-20 Magnetische nanopartikel gehoppelt an annexine und ihre verwendung Withdrawn EP0847528A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9507865 1995-06-29
FR9507865A FR2736197B1 (fr) 1995-06-29 1995-06-29 Nanoparticules magnetiques couplees a de l'annexine et leur utilisation
PCT/FR1996/000964 WO1997001760A1 (fr) 1995-06-29 1996-06-20 Nanoparticules magnetiques couplees a de l'annexine et leur utilisation

Publications (1)

Publication Number Publication Date
EP0847528A1 true EP0847528A1 (de) 1998-06-17

Family

ID=9480536

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96922967A Withdrawn EP0847528A1 (de) 1995-06-29 1996-06-20 Magnetische nanopartikel gehoppelt an annexine und ihre verwendung

Country Status (4)

Country Link
US (1) US6150181A (de)
EP (1) EP0847528A1 (de)
FR (1) FR2736197B1 (de)
WO (1) WO1997001760A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284475B1 (en) * 1997-07-11 2001-09-04 Mount Sinai School Of Medicine Of The City Of New York Assays for diagnosis of thrombophilic disease
IL123429A0 (en) 1998-02-24 1998-09-24 Nst Neurosurvival Technologies Peptides and pharmaceutical compositions comprising same
IL125908A (en) 1998-08-24 2005-05-17 Nst Neurosurvival Technologies Peptides and pharmaceutical compositions comprising same
IL131266A0 (en) 1999-08-05 2001-01-28 N S T Neurosurvival Technologi Peptides and pharmaceutical compositions comprising same
CA2373355A1 (en) * 1999-06-09 2000-12-21 I.D.M. Immuno-Designed Molecules New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
US6562403B2 (en) * 2001-10-15 2003-05-13 Kansas State University Research Foundation Synthesis of substantially monodispersed colloids
SE0202725D0 (sv) * 2002-09-12 2002-09-12 Genovis Ab Anordning för magnetiskt inducerbar membrantransport
FR2848850B1 (fr) * 2002-12-20 2005-06-24 Guerbet Sa Nouvelles compositions de particules magnetiques recouvertes de derives gem-bisphosphonates.
WO2005016414A2 (en) * 2003-08-13 2005-02-24 The Children's Hospital Of Philadelphia Use of receptor sequences for immobilizing gene vectors on surfaces
JP4949041B2 (ja) * 2003-12-18 2012-06-06 マサチューセッツ インスティテュート オブ テクノロジー 磁性ナノ粒子によって促進されたバイオプロセス
US8293522B2 (en) * 2004-05-13 2012-10-23 Centre National De La Recherche Scientifique Device for binding a target entity to a bait entity and detection methods using the same
KR100604976B1 (ko) 2004-09-03 2006-07-28 학교법인연세대학교 다작용기 리간드로 안정화된 수용성 나노입자
US7371327B2 (en) 2005-03-04 2008-05-13 Kenneth Cross Device for the immobilization of nano- and micro-sized particles in a solid-fluid contact vessel facilitating mass-momentum, and heat-transport at the solid-fluid interfaces
FR2921837B1 (fr) * 2007-10-05 2015-07-31 Guerbet Sa Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice organique couplee a des ligands de ciblage
EP3156078B1 (de) 2009-04-10 2020-03-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Fucoidane als liganden zur diagnose degenerativer pathologien
US9409148B2 (en) 2013-08-08 2016-08-09 Uchicago Argonne, Llc Compositions and methods for direct capture of organic materials from process streams
US9579623B2 (en) 2013-11-23 2017-02-28 Kenneth W. Cross Specialized immobilization media
CN112763703B (zh) * 2020-12-31 2023-04-28 深圳天深医疗器械有限公司 一种免疫磁珠及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1040817B (de) * 1956-12-31 1958-10-09 Leybolds Nachfolger E Messsystem fuer Ionisationsmanometer
US4920061A (en) * 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
DE4040817A1 (de) * 1989-12-27 1991-07-04 Boehringer Ingelheim Int Verwendung eines antikoagulant als diagnostikum
FR2662539B1 (fr) * 1990-05-23 1994-09-30 Centre Nat Rech Scient Procede d'obtention de supports magnetiques finement divises par modification controlee de la surface de particules precurseurs magnetiques chargees et produits obtenus.
FR2666443A1 (fr) * 1990-08-31 1992-03-06 Commissariat Energie Atomique Materiau a base de polymere conducteur electronique comprenant des particules magnetiques et son procede de fabrication.
US5294369A (en) * 1990-12-05 1994-03-15 Akzo N.V. Ligand gold bonding
US5610274A (en) * 1991-11-20 1997-03-11 Cpg, Inc. Production and use of magnetic porous inorganic materials
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
US5514340A (en) * 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9701760A1 *

Also Published As

Publication number Publication date
US6150181A (en) 2000-11-21
WO1997001760A1 (fr) 1997-01-16
FR2736197B1 (fr) 1997-09-12
FR2736197A1 (fr) 1997-01-03

Similar Documents

Publication Publication Date Title
EP0847528A1 (de) Magnetische nanopartikel gehoppelt an annexine und ihre verwendung
EP1957978B1 (de) Magnetisch-immundiagnostisches verfahren zur demonstration von antikörper/antigen-komplexen, vor allem von blutgruppen
US4332783A (en) Process for immunologic determination tests
EP0064274B1 (de) Verfahren zur Bestimmung von Antigen-Antikörper-Reaktionen und Reagens hierfür
CA2565114A1 (fr) Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees
EP0311492B1 (de) Immuntestsatz und -verfahren für ganze Zellen
US7553676B2 (en) Specific coupling reaction measuring method
CA1215919A (en) Detection of malignant tumor cells
Klimov et al. On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes
JP4536588B2 (ja) 成人ｔ細胞白血病の診断器具
EP0193439B1 (de) Reagenz zur Bestimmung durch Hämagglutination von Antikörpern gegen Bakterien-Toxine, Verfahren zu ihrer Herstellung und Verwendung
WO1990007118A2 (fr) Anticorps polymerises, diriges contre des immunoglobulines - leur utilisation dans des tests de diagnostic
US5017472A (en) Microflotation devices used for immunoassays and cell/molecular fractionation
JPH10508095A (ja) 体組織全鉄分貯蔵量測定方法
FR2460482A1 (fr) Composition et procede de titrage de l'erythropoietine humaine
D'Alesandro et al. Trypanosoma lewisi: avidity and adsorbability of ablastin, the rat antibody inhibiting parasite reproduction
EP1573336B1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika
JPS6232363A (ja) 抗核抗体の検出方法及び装置
EP0713094A1 (de) Heterogener Immunoassay mittels präzipitierbarer Festphase
EP0598014B1 (de) Verwendung von Atelokollagen als Festträger für die Fixierung eines spezifischen Fängers
WO2010128232A2 (fr) Méthode de diagnostic des infections à propionibacterium acnes
JPH10505423A (ja) 細胞分離
RU2196335C1 (ru) Способ определения гетерогенных антигенов, сходных для микроорганизмов и органов человека и животного
SU1143411A1 (ru) Способ диагностики хронического пиелонефрита
EP1364214A1 (de) Reagenzien zum nachweis von antemortem transmissiblen spongiformen enzephalopathien

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE GB

17Q First examination report despatched

Effective date: 20030814

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060308